These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2960897)

  • 21. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.
    Zijlstra F; de Boer MJ; Hoorntje JC; Reiffers S; Reiber JH; Suryapranata H
    N Engl J Med; 1993 Mar; 328(10):680-4. PubMed ID: 8433726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty.
    Simoons ML; Arnold AE; Betriu A; de Bono DP; Col J; Dougherty FC; von Essen R; Lambertz H; Lubsen J; Meier B
    Lancet; 1988 Jan; 1(8579):197-203. PubMed ID: 2893037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.
    Califf RM; Topol EJ; George BS; Boswick JM; Lee KL; Stump D; Dillon J; Abbottsmith C; Candela RJ; Kereiakes DJ
    Circulation; 1988 May; 77(5):1090-9. PubMed ID: 2966016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group.
    Topol EJ; Califf RM; Vandormael M; Grines CL; George BS; Sanz ML; Wall T; O'Brien M; Schwaiger M; Aguirre FV
    Circulation; 1992 Jun; 85(6):2090-9. PubMed ID: 1591828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
    Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators
    N Engl J Med; 1997 Jun; 336(23):1621-8. PubMed ID: 9173270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.
    Topol EJ; Califf RM; George BS; Kereiakes DJ; Rothbaum D; Candela RJ; Abbotsmith CW; Pinkerton CA; Stump DC; Collen D
    Circulation; 1988 May; 77(5):1100-7. PubMed ID: 2966017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of low-dose mutant tissue-type plasminogen activator followed by planned rescue percutaneous transluminal coronary angioplasty as reperfusion therapy for acute myocardial infarction].
    Tsukahara K; Kimura K; Usui T; Okuda J; Kitamura Y; Kosuge M; Sano T; Tohyama S; Nemoto T; Yamanaka O; Yoshii Y; Tochikubo O; Umemura S
    J Cardiol; 2001 Mar; 37(3):143-50. PubMed ID: 11281054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The European Cooperative Study Group trial of intravenous recombinant tissue-type plasminogen activator (rt-PA) and conservative therapy versus rt-PA and immediate coronary angioplasty.
    de Bono DP
    J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):20A-23A. PubMed ID: 2973485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial.
    Topol EJ; Nicklas JM; Kander NH; Walton JA; Ellis SG; Gorman L; Pitt B
    Am J Cardiol; 1988 Sep; 62(7):368-71. PubMed ID: 2970776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction.
    Ribeiro EE; Silva LA; Carneiro R; D'Oliveira LG; Gasquez A; Amino JG; Tavares JR; Petrizzo A; Torossian S; Duprat Filho R
    J Am Coll Cardiol; 1993 Aug; 22(2):376-80. PubMed ID: 8335807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: a report from the Thrombolysis in Myocardial Infarction (TIMI) Trial.
    Williams DO; Ruocco NA; Forman S
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):45B-50B. PubMed ID: 2959715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Barbash GI; Roth A; Hod H; Modan M; Miller HI; Rath S; Zahav YH; Keren G; Motro M; Shachar A
    Am J Cardiol; 1990 Sep; 66(5):538-45. PubMed ID: 2118299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applicability of percutaneous transluminal coronary angioplasty to patients with recombinant tissue plasminogen activator mediated thrombolysis.
    Topol EJ; Eha JE; Brin KP; Shapiro EP; Weiss JL; Riegel MB; Gottlieb SO; Brinker JA
    Cathet Cardiovasc Diagn; 1985; 11(4):337-48. PubMed ID: 2931176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial.
    Nunn CM; O'Neill WW; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Grines L; Browne KF; Vlietstra RE; Catlin T; Grines CL
    J Am Coll Cardiol; 1999 Mar; 33(3):640-6. PubMed ID: 10080463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Bovill EG; Terrin ML; Stump DC; Berke AD; Frederick M; Collen D; Feit F; Gore JM; Hillis LD; Lambrew CT
    Ann Intern Med; 1991 Aug; 115(4):256-65. PubMed ID: 1906692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of different reperfusion modalities on ventricular function after acute myocardial infarction.
    O'Neill WW
    Am J Cardiol; 1988 May; 61(14):45G-53G. PubMed ID: 2966565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
    Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A
    Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-type plasminogen activator therapy versus primary coronary angioplasty: impact on myocardial tissue perfusion and regional function 1 month after uncomplicated myocardial infarction.
    Agati L; Voci P; Hickle P; Vizza DC; Autore C; Fedele F; Feinstein SB; Dagianti A
    J Am Coll Cardiol; 1998 Feb; 31(2):338-43. PubMed ID: 9462577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction.
    Verstraete M; Bleifeld W; Brower RW; Charbonnier B; Collen D; de Bono DP; Dunning AJ; Lennane RJ; Lubsen J; Mathey DG
    Lancet; 1985 Nov; 2(8462):965-9. PubMed ID: 2865502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trial.
    Topol EJ; Califf RM; Kereiakes DJ; George BS
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):65B-74B. PubMed ID: 2959716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.